ASHP Therapeutic Position Statement on the Institutional Use of 0.9% Sodium Chloride Injection to Maintain Patency of Peripheral Indwelling Intermittent Infusion Devices

in Best Practices
Author:
Bruce Hawkins
DOI:
https://doi.org/10.37573/9781585287048.109
Restricted access